266 related articles for article (PubMed ID: 30975543)
1. Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly.
Chenlo M; Rodriguez-Gomez IA; Serramito R; Garcia-Rendueles AR; Villar-Taibo R; Fernandez-Rodriguez E; Perez-Romero S; Suarez-Fariña M; Garcia-Allut A; Cabezas-Agricola JM; Rodriguez-Garcia J; Lear PV; Alvarez-San Martin RM; Alvarez-Escola C; Bernabeu I; Alvarez CV
EBioMedicine; 2019 May; 43():537-552. PubMed ID: 30975543
[TBL] [Abstract][Full Text] [Related]
2. Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.
Diaz-Rodriguez E; Garcia-Rendueles AR; Ibáñez-Costa A; Gutierrez-Pascual E; Garcia-Lavandeira M; Leal A; Japon MA; Soto A; Venegas E; Tinahones FJ; Garcia-Arnes JA; Benito P; Angeles Galvez M; Jimenez-Reina L; Bernabeu I; Dieguez C; Luque RM; Castaño JP; Alvarez CV
Endocrinology; 2014 Nov; 155(11):4329-40. PubMed ID: 25137025
[TBL] [Abstract][Full Text] [Related]
3. Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells.
Diaz-Rodriguez E; García-Lavandeira M; Perez-Romero S; Senra A; Cañibano C; Palmero I; Borrello MG; Dieguez C; Alvarez CV
Oncogene; 2012 Jun; 31(23):2824-35. PubMed ID: 22020338
[TBL] [Abstract][Full Text] [Related]
4. The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth.
Cañibano C; Rodriguez NL; Saez C; Tovar S; Garcia-Lavandeira M; Borrello MG; Vidal A; Costantini F; Japon M; Dieguez C; Alvarez CV
EMBO J; 2007 Apr; 26(8):2015-28. PubMed ID: 17380130
[TBL] [Abstract][Full Text] [Related]
5. RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas.
Garcia-Rendueles AR; Chenlo M; Oroz-Gonjar F; Solomou A; Mistry A; Barry S; Gaston-Massuet C; Garcia-Lavandeira M; Perez-Romero S; Suarez-Fariña M; Pradilla-Dieste A; Dieguez C; Mehlen P; Korbonits M; Alvarez CV
Oncogene; 2021 Nov; 40(45):6354-6368. PubMed ID: 34588620
[TBL] [Abstract][Full Text] [Related]
6. Infrequent detectable somatic mutations of the RET and glial cell line-derived neurotrophic factor (GDNF) genes in human pituitary adenomas.
Yoshimoto K; Tanaka C; Moritani M; Shimizu E; Yamaoka T; Yamada S; Sano T; Itakura M
Endocr J; 1999 Feb; 46(1):199-207. PubMed ID: 10426588
[TBL] [Abstract][Full Text] [Related]
7. Glial-derived neurotropic factor and RET gene expression in normal human anterior pituitary cell types and in pituitary tumors.
Japón MA; Urbano AG; Sáez C; Segura DI; Cerro AL; Diéguez C; Alvarez CV
J Clin Endocrinol Metab; 2002 Apr; 87(4):1879-84. PubMed ID: 11932334
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of microRNA-216a confers protection against yttrium aluminium garnet laser-induced retinal injury
Hu XB; Fu SH; Luo QI; He JZ; Qiu YF; Lai W; Zhong M
J Biosci; 2018 Dec; 43(5):985-1000. PubMed ID: 30541958
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the tyrosine kinase receptor Ret/glial cell-derived neurotrophic factor (GDNF) signaling: a new player in reproduction induced anterior pituitary plasticity?
Guillou A; Romanò N; Bonnefont X; Le Tissier P; Mollard P; Martin AO
Endocrinology; 2011 Feb; 152(2):515-25. PubMed ID: 21239429
[TBL] [Abstract][Full Text] [Related]
10. GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors.
Morandi A; Martin LA; Gao Q; Pancholi S; Mackay A; Robertson D; Zvelebil M; Dowsett M; Plaza-Menacho I; Isacke CM
Cancer Res; 2013 Jun; 73(12):3783-95. PubMed ID: 23650283
[TBL] [Abstract][Full Text] [Related]
11. Functional role of the RET dependence receptor, GFRa co-receptors and ligands in the pituitary.
Garcia-Lavandeira M; Diaz-Rodriguez E; Garcia-Rendueles MER; Rodrigues JS; Perez-Romero S; Bravo SB; Alvarez CV
Front Horm Res; 2010; 38():127-138. PubMed ID: 20616503
[TBL] [Abstract][Full Text] [Related]
12. ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.
Vieria Neto L; Wildemberg LE; Colli LM; Kasuki L; Marques NV; Moraes AB; Gasparetto EL; Takiya CM; Castro M; Gadelha MR
PLoS One; 2013; 8(10):e77406. PubMed ID: 24098585
[TBL] [Abstract][Full Text] [Related]
13. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.
Sawai H; Okada Y; Kazanjian K; Kim J; Hasan S; Hines OJ; Reber HA; Hoon DS; Eibl G
Cancer Res; 2005 Dec; 65(24):11536-44. PubMed ID: 16357163
[TBL] [Abstract][Full Text] [Related]
14. Smoothened-independent activation of hedgehog signaling by rearranged during transfection promotes neuroblastoma cell proliferation and tumor growth.
Ruan H; Luo H; Wang J; Ji X; Zhang Z; Wu J; Zhang X; Wu X
Biochim Biophys Acta; 2016 Sep; 1860(9):1961-72. PubMed ID: 27316313
[TBL] [Abstract][Full Text] [Related]
15. GDNF induces RET-SRC-HER2-dependent growth in trastuzumab-sensitive but SRC-independent growth in resistant breast tumor cells.
Gardaneh M; Shojaei S; Kaviani A; Behnam B
Breast Cancer Res Treat; 2017 Apr; 162(2):231-241. PubMed ID: 28116540
[TBL] [Abstract][Full Text] [Related]
16. Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy.
Spanheimer PM; Cyr AR; Gillum MP; Woodfield GW; Askeland RW; Weigel RJ
Ann Surg; 2014 Apr; 259(4):793-9. PubMed ID: 24045439
[TBL] [Abstract][Full Text] [Related]
17. Glial cell-line derived neurotrophic factor-mediated RET signaling regulates spermatogonial stem cell fate.
Naughton CK; Jain S; Strickland AM; Gupta A; Milbrandt J
Biol Reprod; 2006 Feb; 74(2):314-21. PubMed ID: 16237148
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D regulation of GDNF/Ret signaling in dopaminergic neurons.
Pertile RAN; Cui X; Hammond L; Eyles DW
FASEB J; 2018 Feb; 32(2):819-828. PubMed ID: 29018141
[TBL] [Abstract][Full Text] [Related]
19. Biphasic functions for the GDNF-Ret signaling pathway in chemosensory neuron development and diversification.
Donnelly CR; Shah AA; Mistretta CM; Bradley RM; Pierchala BA
Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E516-E525. PubMed ID: 29282324
[TBL] [Abstract][Full Text] [Related]
20. Silent somatotroph tumour revisited from a study of 80 patients with and without acromegaly and a review of the literature.
Chinezu L; Vasiljevic A; Trouillas J; Lapoirie M; Jouanneau E; Raverot G
Eur J Endocrinol; 2017 Feb; 176(2):195-201. PubMed ID: 27913611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
